Literature DB >> 17005060

Chest physiotherapy with positive airway pressure: a pilot study of short-term effects on sputum clearance in patients with cystic fibrosis and severe airway obstruction.

Giulia Placidi1, Marta Cornacchia, Guido Polese, Luisa Zanolla, Baroukh M Assael, Cesare Braggion.   

Abstract

BACKGROUND: The periodic administration of positive airway pressure combined with directed cough could aid mucus clearance in patients with cystic fibrosis (CF) and severe airway obstruction.
OBJECTIVE: To compare the short-term effect of positive expiratory pressure (PEP) physiotherapy via mask (mask PEP), continuous positive airway pressure (CPAP), and noninvasive positive-pressure ventilation (NPPV) physiotherapies on amount of sputum collected.
METHODS: Directed cough was standardized for each patient and used as the control treatment. We studied 17 patients with CF (mean +/- SD age 28 +/- 7 y) and severe airway obstruction (forced expiratory volume in the first second 25 +/- 6% of predicted) admitted for pulmonary exacerbation. Mask PEP, CPAP, NPPV, and the control treatment (directed cough) were administered in a random sequence. Each patient received each treatment twice a day (in 70-min sessions) for 2 consecutive days. We measured the wet and dry weight of sputum collected and the number of directed and spontaneous coughs during each session. Spirometry and pulse oximetry were conducted before and after each session. For mask PEP, CPAP, and NPPV, each patient gave a subjective score for the efficacy and tolerability of the treatment, compared to the control treatment.
RESULTS: There was no statistically significant difference in the dry weight of sputum collected: mask PEP 0.9 +/- 0.6 g, CPAP 0.8 +/- 0.4 g, NPPV 0.9 +/- 0.6 g, control treatment 1.0 +/- 0.8 g. There was a statistically significant difference in the wet weight of sputum collected: mask PEP 15.8 +/- 5.5 g, CPAP 13.7 +/- 5.5 g, NPPV 13.2 +/- 5.0 g, control treatment 14.0 +/- 5.0 g (p < 0.05), but that difference became nonsignificant when we took into account the number of spontaneous coughs. There were no statistically significant changes in the spirometry and pulse-oximetry values. The patients' subjective efficacy scores were similar for mask PEP, CPAP, and NPPV. Less fatigue was reported after NPPV and CPAP than after mask PEP.
CONCLUSIONS: There were no differences in sputum clearance or pulmonary-function measures between mask PEP and short-term administration of either CPAP or NPPV combined with directed cough. After mask PEP these patients felt more tired than after CPAP or NPPV secretion-clearance therapy.

Entities:  

Mesh:

Year:  2006        PMID: 17005060

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  10 in total

Review 1.  Non-invasive ventilation for cystic fibrosis.

Authors:  Fidelma Moran; Judy M Bradley; Amanda J Piper
Journal:  Cochrane Database Syst Rev       Date:  2017-02-20

Review 2.  Oxygen therapy for cystic fibrosis.

Authors:  Heather E Elphick; George Mallory
Journal:  Cochrane Database Syst Rev       Date:  2013-07-25

Review 3.  Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis.

Authors:  Louise Warnock; Alison Gates
Journal:  Cochrane Database Syst Rev       Date:  2015-12-21

4.  Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.

Authors:  Maggie McIlwaine; Brenda Button; Sarah J Nevitt
Journal:  Cochrane Database Syst Rev       Date:  2019-11-27

5.  Randomised cross-over trial evaluating the short-term effects of non-invasive ventilation as an adjunct to airway clearance techniques in adults with cystic fibrosis.

Authors:  Gemma Stanford; Helen Parrott; Diana Bilton; Penny Agent; Winston Banya; Nicholas Simmonds
Journal:  BMJ Open Respir Res       Date:  2019-04-14

6.  Comparison of high-flow nasal cannula oxygen therapy and non-invasive ventilation as first-line therapy in respiratory failure: a multicenter retrospective study.

Authors:  Yasutaka Koga; Kotaro Kaneda; Nao Fujii; Ryo Tanaka; Takashi Miyauchi; Motoki Fujita; Kouko Hidaka; Yasutaka Oda; Ryosuke Tsuruta
Journal:  Acute Med Surg       Date:  2019-09-27

7.  Oxygen therapy strategies and techniques to treat hypoxia in COVID-19 patients.

Authors:  B Jiang; H Wei
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-10       Impact factor: 3.784

8.  Eltgol acutelly improves airway clearance and reduces static pulmonary volumes in adult cystic fibrosis patients.

Authors:  Fernando Silva Guimarães; Agnaldo José Lopes; Vanessa Joaquim Ribeiro Moço; Felipe Cavalcanti de Souza; Sara Lúcia Silveira de Menezes
Journal:  J Phys Ther Sci       Date:  2014-06-30

9.  Effect of different breathing aids on ventilation distribution in adults with cystic fibrosis.

Authors:  Markus Wettstein; Lorenz Radlinger; Thomas Riedel
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

10.  Comparison of high-flow nasal oxygen therapy and noninvasive ventilation in COVID-19 patients: a systematic review and meta-analysis.

Authors:  Glenardi Glenardi; Febie Chriestya; Bambang J Oetoro; Ghea Mangkuliguna; Natalia Natalia
Journal:  Acute Crit Care       Date:  2022-02-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.